Use of Clinical Trials Information System becomes mandatory for new clinical trial applications in the EU

  • Home
  • Newsroom
  • Use of Clinical Trials Information System becomes mandatory for new clinical trial applications in the EU
Use of Clinical Trials Information System becomes mandatory for new clinical trial applications in the EU - Axcellant

Use of Clinical Trials Information System becomes mandatory for new clinical trial applications in the EU

  1. sty 31, 2023

From 31 January 2023, all initial clinical trial applications in the European Union (EU) must be submitted via the Clinical Trials Information System (CTIS).

Patrycja Buczak-Kula

CTIS is now the single-entry point for sponsors and regulators of clinical trials for the submission and assessment of clinical trial data. This follows a one-year transition, during which sponsors could choose whether to apply for a new clinical trial in the EU/EEA in line with the Clinical Trials Directive or under the new Clinical Trials Regulation (CTR), which entered into application on 31 January 2022.

https://www.ema.europa.eu/en/news/use-clinical-trials-information-system-becomes-mandatory-new-clinical-trial-applications-eu

Read more

Can AI Write Radiology Reports? A Study Suggests It Can — and Save Time Doing It

A recent publication in npj Digital Medicine explored the use of AI-generated radiology reports — and the results are worth…

Exploring Partnerships and Clinical Innovation in New York

The Axcellant team recently traveled to New York to meet with research partners and clinical collaborators from across the U.S.…

Nuclear Medicine Procedures in Clinical Research: Safety, Standards, and Regulatory Oversight

What Are Nuclear Medicine Procedures and How Are They Used in Clinical Trials? Nuclear medicine procedures (NMPs) are diagnostic and/or…